A new drug could help encourage female orgasms.
Trimel Pharmaceuticals Corp said their new drug could help increase the number of female orgasms achieved in women suffering from orgasmic disorder, Reuters reported.
The company said a dose of 0.6 mg of the drug, dubbed Tefina, could significantly increase the number of orgasms in both pre and post-menopausal women suffering from orgasmic disorder.
To test the drug researchers looked at 253 patients who were either treated with a drug or placebo in an 84-day-long home test.
The drug is administered as a nasal spray. The company did not report their results for other tested doses of the drug
A trial in February 2012 conducted in a hospital setting showed the drug increased the number of orgasms in women suffering from the condition.
The drug "improved sexual functioning and satisfaction, and reduced distress" without showing signs of causing adverse events, Reuters reported.
There is currently no approved medicine for orgasmic disorder, also known as anorgasmia; sometimes patients are given hormone treatments such as patches in hopes of combating the disorder.
"Trimel's stock closed at 70 Canadian cents on Tuesday on the Toronto Stock Exchange," Reuters reported.
Anorgasmia is characterized by a regular difficulty in reaching orgasms, Mayo Clinic reported. It affects more women than most people would think.
"Orgasms vary in intensity, and women vary in the frequency of their orgasms and the amount of stimulation necessary to trigger an orgasm. In fact, fewer than a third of women consistently have orgasms with sexual activity. Plus, orgasms often change with age, medical issues or medications you're taking," Mayo Clinic reported.
Anorgasmia can be caused by a number of thing such as: diseases, gynecological surgeries, alcohol and drug use, and the natural process of aging. It can also be caused by psychological issues and underlying relationship problems.
